Morningstar Investor users sign in here.

Sarah Hansen

Sarah Hansen

is a markets reporter for Morningstar.

Obesity drug stocks: Why it will be ‘exceptionally difficult’ to dethrone Eli Lilly and Novo Nordisk
Stocks
Obesity drug stocks: Why it will be ‘exceptionally difficult’ to dethrone Eli Lilly and Novo Nordisk
The two biggest players in the market appear poised to dominate for years to come.
Is the US stock market expensive right now?
Markets
Is the US stock market expensive right now?
Everything investors need to know about frothy stock valuations, and why they may not be so bad.